Advertisement

Topics

Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales

11:42 EST 8 Nov 2017 | Reuters

(Reuters) - Regeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand for flagship eye treatment Eylea and its new eczema drug Dupixent, boosting its shares alm...

Original Article: Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales

NEXT ARTICLE

More From BioPortfolio on "Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Dermatitis
Dermatitis means an inflammation of the skin. Contact dermatitis is a term used when this inflammation is caused by contact with something in the environment. The changes of dermatitis seen in the skin take the form of eczema; hence it may sometimes be r...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...